More EVE Health Group Limited news
EVE Health Group LimitedASX: EVE

Response to ASX Appendix 4C Query

Feb 19, 2019 at 6:18 AM EST · Issued by EVE Health Group Limited

Filed with ASX · Feb 19, 2019 at 6:18 AM EST

On 6ix: 6ix.com/news/response-to-asx-appendix-4c-query-51

Eve Health Group Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

EVE Health Group Limited on 6ix

Story so far

  • Response to ASX Price & Volume QueryNov 30, 2017

Earlier from EVE Health

  • Meluka Honey Secures Distribution for NSW & ACTNov 13, 2018
  • Meluka Honey Combines Anti-Microbial & Anti-Oxidant ActivityNov 7, 2018
  • Appendix 4E and Full Year Statutory AccountsAug 31, 2018
  • Completion of THC AgreementsJul 24, 2018
  • Omni Innovation - Update by Eagle Health on Chinese MarketJul 15, 2018

Later from EVE Health

  • EVE to Acquire Remaining 50% of Meluka HealthFeb 24, 2019
  • Meluka Honey Appoints OpenDNA for Chinese Market EntryMar 11, 2019
  • PlacementMar 25, 2019
  • Meluka Honey Secures Distribution for Northern NSW & SEQApr 2, 2019
  • THC Global Agreement UpdateMay 14, 2019
All EVE Health news releases↗

Follow EVE Health into a list and get an email when it puts out news.

Follow EVE Health
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer